MedTrace Logo

The Comparison of Two Crosslinked Hyaluronate for the Treatment of Osteoarthritis Pain

NCT04000204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2020-05-27

No results posted yet for this study

Summary

The aim of this study is to compare the safety and effectiveness between two BDDE-crosslinked hyaluronate, HYAJOINT Plus and Durolane, for the Treatment of Knee Osteoarthritis Pain.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

HYAJOINT Plus

60 mg / 3 ml cross-linked hyaluronan, SciVision Biotech Inc.

DEVICE

Durolane

60 mg / 3 ml cross-linked hyaluronan, Bioventus LLC.

Sponsors & Collaborators

  • SciVision Biotech Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-20
Primary Completion
2018-06-15
Completion
2019-07-12

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04000204 on ClinicalTrials.gov